The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...
Represents second complex respiratory therapeutic product approval in Q4 2025BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE ...
Seven Proventil HFA (albuterol sulfate 6.7 g hydrofluoroalkane inhalation aerosol) a and seven Ventolin HFA (albuterol sulfate 18 g hydrofluoroalkane inhalation aerosol) b MDIs were acquired from a ...
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate ...
WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...
Cipla is notifying its distributors and customers by letter and is arranging for the return and replacement of all recalled products.(Bloomberg) Cipla Limited today announced that its wholly-owned ...